TrialAesthetic surgery journal2022

Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines.

John H Joseph et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.